SCHEMBL6949542

SCHEMBL6949542

CCOc1ccccc1N/C=C1\C(=O)N(c2ccc(S(=O)(=O)N(CC)CC)cc2)N=C1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.47
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 5/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
THRB P10828 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 2/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
MDM4 O15151 1/20 0.40
MDM2 Q00987 1/20 0.40
KAT8 Q9H7Z6 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GAA P10253 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
AMY1A P0DUB6 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949544 1.00 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1THRB
SCHEMBL8428064 0.95 PTGS2 (0.45) PTGS2ALDH1A1KMT2AL3MBTL1THRB
SCHEMBL8428063 0.95 PTGS2 (0.45) PTGS2ALDH1A1KMT2AL3MBTL1THRB
SCHEMBL6949810 0.92 KMT2A (0.47) PTGS2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL6949812 0.92 KMT2A (0.47) PTGS2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL6950421 0.88 PTGS2 (0.60) PTGS2ALDH1A1KMT2AL3MBTL1NPSR1
SCHEMBL6950419 0.88 PTGS2 (0.60) PTGS2ALDH1A1KMT2AL3MBTL1NPSR1
SCHEMBL8424072 0.87 KMT2A (0.43) PTGS2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL8424070 0.87 KMT2A (0.43) PTGS2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL6947265 0.87 KAT8 (0.42) PTGS2ALDH1A1KMT2AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed